ALPS ADVISORS INC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1376113 Denver, CO

Position in AMLX

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$1,250,763

+$161,486 QoQ

Shares Held

89,983

-0.2% QoQ

Ownership

0.081%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ALPS ADVISORS INC holds $13,007,217 across 10 Drug Manufacturers - Specialty & Generic names. AMLX ranks #3 (9.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	135,660	$4,796,937
2	ZTS	Zoetis Inc.	26,087	$3,083,744
3	AMLX	Amylyx Pharmaceuticals, Inc. This page	89,983	$1,250,763
4	RDY	Dr Reddys Laboratories Ltd	63,836	$884,128
5	BCRX	Biocryst Pharmaceuticals Inc	60,250	$573,580
6	PAHC	Phibro Animal Health Corp	10,010	$553,653
7	UTHR	UNITED THERAPEUTICS Corp	921	$546,134
8	ANIP	Ani Pharmaceuticals Inc	7,030	$540,607

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,250,763	89,983	-0.2%	Shares	Defined	2026-05-08
2025-12-31	$1,089,277	90,172	+33.4%	Shares	Defined	2026-02-12
2025-03-31	$239,293	67,597	+22.0%	Shares	Defined	2025-04-30
2024-12-31	$209,525	55,430	-38.7%	Shares	Defined	2025-02-13
2024-06-30	$171,678	90,357	-35.1%	Shares	Defined	2024-08-13
2024-03-31	$395,470	139,250	+180.0%	Shares	Defined	2024-05-14
2023-12-31	$731,996	49,728	+0.1%	Shares	Defined	2024-02-14
2023-09-30	$909,933	49,696	+0.6%	Shares	Defined	2023-11-14
2023-06-30	$1,065,126	49,380	+13.1%	Shares	Defined	2023-08-14
2023-03-31	$1,280,867	43,656	-2.8%	Shares	Defined	2023-05-10
2022-12-31	$1,659,498	44,912	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.